Literature DB >> 6487498

Omeprazole inhibition of nocturnal gastric secretion in patients with duodenal ulcer.

D J Hetzel, D J Shearman.   

Abstract

We studied the effect of single 08.00 h doses of omeprazole or placebo on gastric acid secretion during the following night, 14 to 23 h after administration, in seven male subjects with duodenal ulcer. The drug was given orally, double-blind, in randomized order. Omeprazole 20 mg, 40 mg and 80 mg reduced mean total overnight acid output by 43%, 73% and 91% respectively and median pH increased from 1.4 with placebo to 1.6, 3.1 and 7.0 respectively. The inhibitory effect was maintained throughout the study period. No clinical side effects or abnormalities of laboratory screening tests were seen. Omeprazole is well tolerated and administration at 08.00 h produces prolonged dose related inhibition of acid output during the following night.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487498      PMCID: PMC1463604          DOI: 10.1111/j.1365-2125.1984.tb02508.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  A study of the changes in pH of gastric contents in peptic ulcer using the twenty-four hour test meal.

Authors:  G WATKINSON
Journal:  Gastroenterology       Date:  1951-07       Impact factor: 22.682

2.  Cimetidine suppression of nocturnal gastric secretion in active duodenal ulcer.

Authors:  G F Longstreth; V L Go; J R Malagelada
Journal:  N Engl J Med       Date:  1976-04-08       Impact factor: 91.245

3.  Effect of repeated, once daily, oral omeprazole on gastric secretion.

Authors:  P Müller; H G Dammann; H Seitz; B Simon
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

4.  Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release.

Authors:  W Londong; V Londong; C Cederberg; H Steffen
Journal:  Gastroenterology       Date:  1983-12       Impact factor: 22.682

5.  Gastric secretion tests.

Authors:  L R Dragstedt
Journal:  Gastroenterology       Date:  1967-03       Impact factor: 22.682

6.  Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.

Authors:  E Fellenius; T Berglindh; G Sachs; L Olbe; B Elander; S E Sjöstrand; B Wallmark
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

7.  Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.

Authors:  T Lind; C Cederberg; G Ekenved; U Haglund; L Olbe
Journal:  Gut       Date:  1983-04       Impact factor: 23.059

8.  Effect of daily oral omeprazole on 24 hour intragastric acidity.

Authors:  R P Walt; M D Gomes; E C Wood; L H Logan; R E Pounder
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-02

9.  Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study.

Authors:  W L Burland; B W Hawkins; J Beresford
Journal:  Postgrad Med J       Date:  1980-03       Impact factor: 2.401

  9 in total
  2 in total

1.  Abolition by omeprazole of aspirin induced gastric mucosal injury in man.

Authors:  T K Daneshmend; A G Stein; N K Bhaskar; C J Hawkey
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

Review 2.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.